Electromed price target raised to $33 from $26 at Lake Street

Lake Street analyst Brooks O’Neil raised the firm’s price target on Electromed (ELMD) to $33 from $26 and keeps a Buy rating on the shares after the company posted “solid” Q1 results. The stock has done “extremely well” with a 141% year-to-date increase, but the firm believes there is “still room for multiple expansion given continued strong growth and solid execution,” the analyst tells investors.